Table 1.
Baseline Demographic, Clinical, Endoscopic, and Histologic Characteristics
| Overall (N = 41) | |
|---|---|
|
| |
| Demographics, n (%) | |
| Age, y, mean [IQR] | 9 [6–13] |
| Male | 31 (76) |
| White | 36 (88) |
| Hispanic | 2 (5) |
| Atopy/comorbidities, n (%) | |
| Allergic rhinitis | 27 (66) |
| Asthma | 14 (34) |
| Conjunctivitis | 2 (5) |
| Drug allergy | 6 (15) |
| Eczema | 10 (24) |
| Gastroesophageal reflux disease | 6 (15) |
| IgE-mediated food allergy | 13 (32) |
| Family history, n (%) | |
| Allergic rhinitis | 26 (63) |
| Asthma | 22 (54) |
| Celiac disease | 6 (15) |
| Colitis | 2 (5) |
| Crohn’s disease | 2 (5) |
| Eczema | 13 (32) |
| EoE | 6 (15) |
| Esophageal stricture | 5 (12) |
| IgE-mediated food allergy | 15 (37) |
| Gastroesophageal reflux disease | 21 (51) |
| Hiatal hernia | 7 (17) |
| Medications at enrollment, n (%) | |
| Proton pump inhibitor | 37 (90) |
| Antihistamine | 11 (27) |
| Bronchodilator | 8 (20) |
| EpiPen (carries) | 15 (37) |
| Inhaled corticosteroid | 5 (12) |
| Intranasal corticosteroid | 7 (17) |
| Montelukast | 4 (10) |
| Topical steroid | 0 (0) |
| Skin prick test, n (%) | |
| Any abnormal (n = 23) | 15 (65) |
| Milk abnormal (n = 18) | 2 (11) |
| Food sensitization on RAST, n (%) | |
| Any abnormal (n = 23) | 18 (78) |
| Milk abnormal (n = 21) | 9 (43) |
| Prior treatment, n (%) | |
| Swallowed steroida | 8 (20) |
EoE, eosinophilic esophagitis; IQR, interquartile range; RAST, radioallergosorbent test.
a
Swallowed steroids included fluticasone inhaler or viscous budesonide.